Search Results 31-40 of 17051 for Aubagio

  1. Mayo Clinic

    Share · Tweet . IMG-20448211. Home; find-cure-appignanis-12col. Fuel groundbreaking medical research! Give Today. Your donation powers the future of ...

  2. Upadacitinib (oral route) - Side effects & dosage - Mayo Clinic

    Description. Upadacitinib is used to treat moderate to severe active rheumatoid arthritis, active psoriatic arthritis, ankylosing spondylitis, ...

  3. News - William A. Faubion, Jr., M.D. - Mayo Clinic

    Search for a doctor. William A. Faubion, Jr., M.D.. Gastroenterologist. Request an Appointment · Overview · News. News.

  4. Dipyridamole (oral route, intravenous route) - Side effects & dosage - Mayo Clinic

    Dipyridamole is used to lessen the chance of stroke or other serious medical problems that may occur when a blood vessel is blocked by blood clots. It is given ...

  5. Rubidium rb 82 (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine shows how much blood is getting to your heart muscle when you are resting or exercising (stressed). Rubidium Rb 82 injection is a ...

  6. Budesonide (inhalation route) - Side effects & dosage - Mayo Clinic

    When used regularly every day, inhaled budesonide decreases the number and severity of asthma attacks. However, it will not relieve an asthma attack that has ...

  7. Raxibacumab (intravenous route) - Side effects & uses - Mayo Clinic

    Raxibacumab injection is given with antibiotic medicines to treat inhalational anthrax. It is also used to prevent inhalational anthrax when there are no other ...

  8. Mayo Clinic

    Share · Tweet . IMG-20076959. Home; SN00021Solarlentiginesontheback. Fuel groundbreaking medical research! Give Today. Your donation powers the future of ...

  9. Non Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  10. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

    About this study. The purpose of this study is to confirm and extend the results observed in the Phase 1 and 2a studies with BMS-986036.